A Virtual Reality View: Selecting Disease-Modifying Therapy for Multiple Sclerosis: Tools to Achieve and Maintain Control of a Dynamic Disease

RELEASE DATE: June 16, 2020

EXPIRATION DATE: June 16, 2021

FACULTY
Patricia K. Coyle, MD, FAAN, FANA
Professor and Interim Chair
Director, MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, New York

PROGRAM OVERVIEW
This activity will cover the treatment and management of patients with multiple sclerosis (MS).

TARGET AUDIENCE
This activity is designed to meet the needs of neurologists, nurses, nurse practitioners, and other healthcare professionals treating patients with MS.

LEARNING OBJECTIVES
After completing the CME activity, learners should be better able to:

  • Review MS classification and differences in presentation to encourage earlier diagnosis and prompt initiation of treatment
  • Improve clinician/patient communication and patient engagement to better pursue favorable outcomes
  • Establish ways in which to overcome barriers to adherence in MS treatment
  • Evaluate the safety and efficacy of current and emerging agents used for MS

ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT
Med Learning Group designates this web-based activity for a maximum of 1.25 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with MS.

CNE Credits: 1.25 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.25 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.

DISCLOSURE OF FINANCIAL RELATIONSHIPS
FACULTY
Patricia Coyle, MD, FAAN, has received consultant fees from Accordant, Alexion, Bayer, Biogen Idec, Celgene, Genentech/Roche, Genzyme/Sanofi, GlaxoSmithKline, Mylar, Novartis, Serono, and TG Therapeutics. Dr. Coyle has received research funding from Actelion, Alkermes, Corrona LLD, Genentech/Roche, MedDay, NINDS, and Novartis and PCORI.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.

Christina Gallo, SVP, Educational Development of Med Learning Group has nothing to disclose.

Ashley Whitehurst, Program Manager of Med Learning Group has nothing to disclose.

Chris Drury, Medical Director of Med Learning Group has nothing to disclose.

Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group has nothing to disclose.

Russie Allen, Accreditation and Outcomes Coordinator of Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity; and
3. Complete pre-and-post surveys and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

RELEASE DATE: June 16, 2020

EXPIRATION DATE: June 16, 2021

AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

About Me

The Continuing Medical Education Program is an integral part of the organization’s overall mission which aims to improve learners’ competence and performance‐in‐practice and ultimately improve patient outcomes.

Related Posts